✦ LIBER ✦

Association Study of Selected Genetic Polymorphisms and Occurrence of Venous Thromboembolism in Patients With Multiple Myeloma Who Were Treated With Thalidomide

✍ Scribed by Martina Almasi; Sabina Sevcikova; Ondrej Slaby; Petra Kaisarova; Vladimir Maisnar; Miroslav Penka; Tomas Pika; Ludek Pour; Jakub Radocha; Vlastimil Scudla; Hana Svachova; Roman Hajek

Book ID: 119218727
Publisher: Elsevier
Year: 2011
Tongue: English
Weight: 271 KB
Volume: 11
Category: Article
ISSN: 2152-2650
DOI: 10.1016/j.clml.2011.03.024

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Prevention of venous thromboembolism wit

Prevention of venous thromboembolism with low molecular-weight heparin in patients with multiple myeloma treated with thalidomide and chemotherapy

✍ Minnema, M C; Breitkreutz, I; Auwerda, J J A; van der Holt, B; Cremer, F W; van 📂 Article 📅 2004 🏛 Nature Publishing Group 🌐 English ⚖ 87 KB

Prophylactic recombinant erythropoietin

Prophylactic recombinant erythropoietin therapy and thalidomide are predictors of venous thromboembolism in patients with multiple myeloma: limited effectiveness of thromboprophylaxis

✍ Elias J. Anaissie; Elizabeth A. Coleman; Julia A. Goodwin; Robert L. Kennedy; Ki 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 186 KB 👁 1 views

## Abstract ## BACKGROUND: Venous thromboembolism (VTE) is a significant but poorly understood complication in patients with newly diagnosed multiple myeloma (NDMM). As a result, most patients receive thromboprophylaxis with low molecular weight heparin (LMWH). The purpose of this retrospective st

Rates of venous thromboembolism in multi

Rates of venous thromboembolism in multiple myeloma patients undergoing immunomodulatory therapy with thalidomide or lenalidomide: a systematic review and meta-analysis

✍ M. CARRIER; G. LE GAL; J. TAY; C. WU; A. Y. LEE 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 151 KB

Impact on response and survival of DNA r

Impact on response and survival of DNA repair single nucleotide polymorphisms in relapsed or refractory multiple myeloma patients treated with thalidomide

✍ María Teresa Cibeira; Carlos Fernández de Larrea; Alfons Navarro; Tania Díaz; Do 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 332 KB

Enoxaparin or aspirin for the prevention

Enoxaparin or aspirin for the prevention of recurrent thromboembolism in newly diagnosed myeloma patients treated with melphalan and prednisone plus thalidomide or lenalidomide

✍ A. PALUMBO; C. RUS; J. B. ZELDIS; F. RODEGHIERO; M. BOCCADORO; THE ITALIAN MULTI 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 120 KB

Single nucleotide polymorphisms in the p

Single nucleotide polymorphisms in the promoter region of theIL1Bgene influence outcome in multiple myeloma patients treated with high-dose chemotherapy independently of relapse treatment with thalidomide and bortezomib

✍ Annette J. Vangsted; Tobias W. Klausen; Niels Abildgaard; Niels F. Andersen; Pet 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 509 KB